News Coverage 10.17.19 By: Adam Feuerstein Share on Twitter Share on Facebook Share on LinkedIn Sean Parker, billionaire and philanthropist, gets an immunotherapy company off the ground Related Announcement, Press Release Alliance Aims to Develop Next-Gen Cancer Therapies Announcement, Press Release Biomarkers May Predict Better Treatment Options Announcement, Press Release First Patients Dosed in Pancreatic Platform Trial